Chevron Left
Back to Intellectual Property in the Healthcare Industry

Learner Reviews & Feedback for Intellectual Property in the Healthcare Industry by University of Pennsylvania

4.8
stars
148 ratings

About the Course

This course begins with an overview of general intellectual property law in the United States, then examines how the policy choices behind those laws shapes the behavior of major players in the healthcare industry. We will examine how patents and trademarks shape the behavior of pharmaceutical companies, and how complex issues involving medical research in university settings, and ownership of genetic information and material, are resolved by intellectual property laws. The course concludes with in-depth case studies of an international pharmaceutical company, a major medical device company, and a start-up in the emerging DNA-testing industry....

Top reviews

NK

Jul 14, 2023

THIS IS A SUITABLE COURSE TO UNDERSTAND INTELLECTUAL PROPERTY LAW OF AMERICA. THE ORGANIZERS KEEP THE MOMENTUM BY THE TIMELY INTERCEPTIONS DURING THE COURSE.

AM

Jan 13, 2021

Covered the major topics in Healthcare Industry IP. I highly recommend to all interested in this area of law.

Filter by:

26 - 37 of 37 Reviews for Intellectual Property in the Healthcare Industry

By PRIYA S

•

May 25, 2021

It was nice and helpful

By pradeep K

•

Apr 10, 2022

Highly qulty contact

By Anitha R

•

Jul 9, 2022

informative course

By Diego R

•

Apr 26, 2020

Very good course

By John W

•

Oct 27, 2023

Great course!!!

By Anagha T

•

Oct 19, 2020

great learning

By Tonya S W

•

May 2, 2020

Thank you

By Christian S

•

Jul 26, 2022

Great course on a very interesting subject, would be good to have something similar on other countries.

By swarnalatha n

•

Mar 14, 2025

very informative

By Giovanni P

•

Mar 25, 2020

Only a few modules are really interesting and new: the rest is the same as in other courses by the Penn.

By Mankar M P .

•

Nov 17, 2025

Case studies should be more video content should be more

By SHUBHRA K

•

Sep 20, 2024

good